Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Lodwick

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Plos One|March 16, 2017
Death following partner bereavement: A self-controlled case series analysisMichael King, Rebecca Lodwick, Rebecca Jones, et al.
Age and Ageing|December 6, 2016
Inequalities in receipt of mental and physical healthcare in people with dementia in the UKClaudia Cooper, Rebecca Lodwick, Kate Walters, et al.
Age and Ageing|November 20, 2015
Observational cohort study: deprivation and access to anti-dementia drugs in the UKClaudia Cooper, Rebecca Lodwick, Kate Walters, et al.
Journal of Pain and Symptom Management|February 20, 2016
Living With an Older Person Dying From Cancer, Lung Disease, or Dementia: Health Outcomes From a General Practice Cohort StudyElizabeth L Sampson, Rebecca Lodwick, Greta Rait, et al.
AIDS (London, England)|May 24, 2013
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAlison J Rodger, Rebecca Lodwick, Mauro Schechter, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2015
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation ModelFumiyo Nakagawa, Ard van Sighem, Rodolphe Thiebaut, et al.
The Lancet. Infectious Diseases|October 13, 2011
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study, , Dominique Costagliola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe, , Fumiyo Nakagawa, et al.
The Journal of Infectious Diseases|December 11, 2012
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes, Dominique Costagliola, Bruno Ledergerber, et al.
Archives of Internal Medicine|March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years, Rebecca Lodwick, Dominique Costagliola, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|March 16, 2017
Death following partner bereavement: A self-controlled case series analysisMichael King, Rebecca Lodwick, Rebecca Jones, et al.
Age and Ageing|December 6, 2016
Inequalities in receipt of mental and physical healthcare in people with dementia in the UKClaudia Cooper, Rebecca Lodwick, Kate Walters, et al.
Age and Ageing|November 20, 2015
Observational cohort study: deprivation and access to anti-dementia drugs in the UKClaudia Cooper, Rebecca Lodwick, Kate Walters, et al.
Journal of Pain and Symptom Management|February 20, 2016
Living With an Older Person Dying From Cancer, Lung Disease, or Dementia: Health Outcomes From a General Practice Cohort StudyElizabeth L Sampson, Rebecca Lodwick, Greta Rait, et al.
AIDS (London, England)|May 24, 2013
Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general populationAlison J Rodger, Rebecca Lodwick, Mauro Schechter, et al.
Epidemiology (Cambridge, Mass.)|November 26, 2015
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation ModelFumiyo Nakagawa, Ard van Sighem, Rodolphe Thiebaut, et al.
The Lancet. Infectious Diseases|October 13, 2011
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study, , Dominique Costagliola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe, , Fumiyo Nakagawa, et al.
The Journal of Infectious Diseases|December 11, 2012
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes, Dominique Costagliola, Bruno Ledergerber, et al.
Archives of Internal Medicine|March 10, 2010
Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years, Rebecca Lodwick, Dominique Costagliola, et al.
Pageof 1